Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-19 of 19
Keywords: Cisplatin
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2021) 105 (3-4): 257–263.
Published Online: 24 February 2021
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2020 Testicular germ cell tumour Thrombosis Pulmonary embolism Cisplatin Chemotherapy Central venous access system Testicular germ...
Journal Articles
Subject Area:
Further Areas
Serkan Dogan, Martin Hennig, Tanja Frank, Julian P. Struck, Angelika Cebulla, Johannes Salem, Hendrik Borgmann, Tobias Klatte, Axel S. Merseburger, Mario Kramer, Sebastian L. Hofbauer
Journal:
Urologia Internationalis
Urol Int (2018) 101 (1): 25–30.
Published Online: 06 March 2018
...%) participants were stated to regularly use NAC and AC respectively. The number of participants who were stated to use NAC and AC regularly was not associated with the type of institution (academic vs. nonacademic), number of hospital beds, and number of cystectomies performed annually. Gemcitabine/cisplatin...
Journal Articles
Subject Area:
Further Areas
Kazuhiro Nagao, Takahiko Hara, Jun Nishijima, Kosuke Shimizu, Nakanori Fujii, Keita Kobayashi, Yoshihisa Kawai, Ryo Inoue, Yoshiaki Yamamoto, Hiroaki Matsumoto, Hideyasu Matsuyama
Journal:
Urologia Internationalis
Urol Int (2017) 99 (4): 446–452.
Published Online: 21 June 2017
... with MIBC treated by trimodal chemoradiotherapy with cisplatin (CDDP-radiation [CDDP-R]). Transurethral resection of the bladder tumor (TURBT) was performed before treatment to confirm pathological stage ≥T2. Extensive TURBT was performed after chemoradiotherapy to evaluate the pathological response...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2017) 99 (1): 104–109.
Published Online: 18 May 2017
...Isabel Heidegger; Daniel Porres; Nica Veek; Axel Heidenreich; David Pfister Background: Malignancies and cisplatin-based chemotherapy are both known to correlate with a high risk of venous thrombotic events (VTT). In testicular cancer, the information regarding the incidence and reason of VTT...
Journal Articles
Subject Area:
Further Areas
L. Solari, M. Krönig, G. Ihorst, K. Drognitz, J. Heinz, C.A. Jilg, W. Schultze-Seemann, M. Engelhardt, Cornelius F. Waller
Journal:
Urologia Internationalis
Urol Int (2016) 96 (4): 399–405.
Published Online: 14 April 2016
... cancer patients undergoing cisplatin-based chemotherapy. Patients and Methods: LMWH prophylaxis was given from the first day of chemotherapy until 21 days after completing the last chemotherapy cycle to 45 out of 93 (48.4%) patients (extended), and to 48 out of 93 (51.6%) patients during...
Journal Articles
Subject Area:
Further Areas
Omar Fahmy, Marcus Scharpf, Tina Schubert, Susan Feyerabend, Arnulf Stenzl, Christian Schwentner, Falko Fend, Georgios Gakis
Journal:
Urologia Internationalis
Urol Int (2016) 97 (4): 485–488.
Published Online: 11 February 2016
..., but developed pulmonary metastatic disease 7 months postoperatively. Six cycles of gemcitabine/cisplatin combination chemotherapy with an addition of gefitinib as daily oral medication were administered within a randomized phase II clinical trial; this resulted in complete remission of the pulmonary metastases...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2016) 96 (1): 5–13.
Published Online: 06 June 2015
.... Methods: Chemotherapy-naïve patients with advanced or metastatic urothelial carcinoma were randomized 1:1:1 to receive six cycles of chemotherapy (gemcitabine 1,250 mg/m 2 on days 1 and 8, and cisplatin 70 mg/m 2 on day 1 of every cycle) concomitantly with gefitinib 250 mg/day (arm A); or with sequential...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2013) 91 (4): 445–450.
Published Online: 06 September 2013
... of spermatogenesis in testicular cancer patients following chemotherapy. Patients and Methods: 49 patients, consisting of 45 treated with a bleomycin, etoposide and cisplatin (BEP) regimen and 4 with high-dose chemotherapy, were followed up with occasional semen analyses. The primary endpoint of this study...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1996) 57 (2): 99–103.
Published Online: 04 February 2010
...İ. Deǧ;irmenci; A. Başaran; K. Erol; E. Açikalin; H.V. Güneş; S. Yazıcıoǧ;lu; A.G. Tomatír; H. Gün In the present study, some toxic effects of cisplatin are evaluated in rats. It was also investigated whether S-carboxymethylcysteine (S-CMC), a free radical scavenger, protects the experimental...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1995) 54 (2): 80–84.
Published Online: 03 February 2010
...Mikio Igawa; Hitoshi Kadena; Takatoshi Tacho; Takahisa Nakamoto; Tsuguru Usui Thirty-seven patients with urothelial cancer were given combination chemotherapy with methotrexate, etoposide and cisplatin. Thirty patients were evaluated for response. Response rates were 50% in the primary organ, 50...
Journal Articles
Subject Area:
Further Areas
Jiro Uozumi, Toyofumi Ueda, Tetsuo Yasumasu, Yasuhiro Koikawa, Seiji Naito, Joichi Kumazawa, Toshiharu Kamura, Hitoo Nakano, Katsuo Sueishi
Journal:
Urologia Internationalis
Urol Int (1993) 51 (2): 57–61.
Published Online: 03 February 2010
...Jiro Uozumi; Toyofumi Ueda; Tetsuo Yasumasu; Yasuhiro Koikawa; Seiji Naito; Joichi Kumazawa; Toshiharu Kamura; Hitoo Nakano; Katsuo Sueishi To evaluate the effects of repeated administration of cisplatin on kidney platinum (Pt) accumulation and renal function, Pt content in the kidney...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1996) 56 (3): 174–179.
Published Online: 03 February 2010
...M. Takashi; Y. Zhu; K. Miyake; K. Kato Calbindin-D, a vitamin D-dependent calcium-binding protein of 28 kD, is found predominantly in the distal tubules of the kidney and central nervous system tissues in humans. To evaluate damage to the renal tubules caused by cisplatin-based chemotherapy, levels...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1995) 55 (4): 215–217.
Published Online: 03 February 2010
... months after the second treatment, multiple lung metastasis and a second local recurrence in the inguinal skin were found. High-dose chemotherapy with cisplatin and doxorubicin was performed, but no change was confirmed after 4 weeks. The disease progressed, resulting in death within 8 months...
Journal Articles
Subject Area:
Further Areas
M. Matsushima, T. Tajima, T. Kase, M. Harada, M. Takanami, T. Yagishita, Y. Sawamura, M. Shirai, I. Kaneko, K. Kuwashima, N. Nakayama, R. Suzuki
Journal:
Urologia Internationalis
Urol Int (1991) 47 (Suppl. 1): 138–142.
Published Online: 03 February 2010
...M. Matsushima; T. Tajima; T. Kase; M. Harada; M. Takanami; T. Yagishita; Y. Sawamura; M. Shirai; I. Kaneko; K. Kuwashima; N. Nakayama; R. Suzuki Since September 1985, 44 patients with advanced urinary bladder cancer have been treated by combined cisplatin and full-dose radiotherapy. The patients...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1984) 39 (2): 73–79.
Published Online: 29 January 2010
...U. Engelmann; J. Krug; W. Sonntag; G.H. Jacobi The influence of a single dose cisplatin on wound healing of enterostomies in rats was investigated by measurement of the wound-breaking strength, microangiographically and histologically. Cisplatin (5 mg/kg body weight) was given on day ––1 or day ––5...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2006) 77 (4): 355–361.
Published Online: 28 November 2006
.... The combination effect of rAAV-wt-p53 and cisplatin was measured by MTT assay. Results: The virus rAAV efficiently enters the cells and expresses its gene products. The gene product of rAAV-wt-p53 is cytotoxic to bladder cancer cells. The bladder cell line 5637 was found to experience a synergistic killing effect...
Journal Articles
Subject Area:
Further Areas
Meltem Ozlen Dillioglugil, Hale Maral Kir, Mehmet Dogan Gulkac, Aylin Özon Kanli, Hacı Kahya Ozdogan, Oguz Acar, Ozdal Dillioglugil
Journal:
Urologia Internationalis
Urol Int (2005) 75 (4): 340–344.
Published Online: 02 December 2005
...Meltem Ozlen Dillioglugil; Hale Maral Kir; Mehmet Dogan Gulkac; Aylin Özon Kanli; Hacı Kahya Ozdogan; Oguz Acar; Ozdal Dillioglugil Objective: Cisplatin (DDP, cis -diamminedichloroplatinium II) is one of the most potent chemotherapeutic antitumor drugs, but is able to generate reactive oxygen...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2003) 71 (1): 37–40.
Published Online: 04 July 2003
...Enrico Meliani; Alberto Lapini; Sergio Serni; Cristoforo Corvino; Marco Carini Objective: To evaluate the toxicity of gemcitabine and cisplatin combination therapy in adjuvant regimen after radical cystectomy for muscle invasive bladder cancer. Patients and Methods: Forty patients underwent radical...
Journal Articles
Subject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2001) 67 (1): 54–58.
Published Online: 18 July 2001
... were scheduled for 4 cycles of bleomycin-etoposide-cisplatin (BEP) or methotrexate-vinblastine-etoposide-cisplatin (MVEC) combination chemotherapy, respectively. At each cycle the whole cisplatin dose was given in 1 day that is 100 mg/m 2 /day in the BEP and 70 mg/m 2 /day in the MVEC protocols...